| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/2004 | US20040180808 Multiple sclerosis; molecules related to 21.5 kDa fetal isoform; inducing selective T cell apoptosis; kits |
| 09/16/2004 | US20040180440 Modified AAV |
| 09/16/2004 | US20040180432 Propagating human hematopoietic cells in culture via inoculation of bioreactor nutrient broth with transgenic stromal cells expressing growth factor proteins and perfusion of progenitor cells with medium with subsequent recovery of hematopoietic tissue |
| 09/16/2004 | US20040180421 Purification process |
| 09/16/2004 | US20040180417 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin2) |
| 09/16/2004 | US20040180415 Isolating fusion protein comprised of metal affinity peptide using immobilized metal ion affinity chromatography (IMAC) |
| 09/16/2004 | US20040180409 TLT-1, a novel platelet-associated receptor and uses therefor |
| 09/16/2004 | US20040180408 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180405 Novel potassium channels and genes encoding these potassium channels |
| 09/16/2004 | US20040180404 Transgenic proteobacterium comprising mutation in aerobic respiration control (ARC) for preparation and generation of glutamic acid and lysine for use in cosmetics, animal feeds and medicines |
| 09/16/2004 | US20040180402 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/16/2004 | US20040180401 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 09/16/2004 | US20040180399 Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 09/16/2004 | US20040180398 Membrane receptor protein for monitoring metabolism and differentiation of cells |
| 09/16/2004 | US20040180396 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 09/16/2004 | US20040180389 antigen bearing target and a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide; immunotherapy; e.g. fusion protein of a lectin and a ligand of a cell surface receptor of an antigen presenting cell |
| 09/16/2004 | US20040180386 Using major histocompatibility complex polypeptides as tools in identifying lymphocyte binding sites; immunosuppression and tumor therapeutics |
| 09/16/2004 | US20040180378 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 09/16/2004 | US20040180375 AGS proteins and nucleic acid molecules and uses therefor |
| 09/16/2004 | US20040180371 Nucleotide sequences coding novel serine protease for identifying modulator for diagnosis, treatment and prevention of cell proliferative disorders |
| 09/16/2004 | US20040180359 Nucleotide sequences which code for the rpoB gene |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180344 Novel therapeutic targets in cancer |
| 09/16/2004 | US20040180342 Sulfolobus multimeric nucleotide sequence binding protein for use as stabilization tool in DNA amplification |
| 09/16/2004 | US20040180340 Method for creating polynucleotide and polypeptide sequences |
| 09/16/2004 | US20040180339 Comprises nucleotide sequences coding endometrioid carcinoma 1 (ECA1) gene for use in identifying modulator for treatment and prevention of cell proliferative disorders of urogenital systems; cancer diagnosis |
| 09/16/2004 | US20040180335 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment of epileptic, autoimmune and nervous system disorders |
| 09/16/2004 | US20040180333 Self-replicating RNA molecule from hepatitis C virus |
| 09/16/2004 | US20040180329 Synthetic HIV gag genes |
| 09/16/2004 | US20040180326 Avian leukosis viruses and polypeptide display |
| 09/16/2004 | US20040180324 Identifying insulin producing beta cell proliferating factor in oocyte fluids for use in treatment of diabetes |
| 09/16/2004 | US20040180064 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV) |
| 09/16/2004 | US20040180063 Vaccination with peptide of MHC class ll molecules for treatment of autoimmune disease |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |
| 09/16/2004 | US20040180056 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180048 Administering to a subject in need thereof an effective amount of an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker (NM) protein |
| 09/16/2004 | US20040180038 Effectors of innate immunity determination |
| 09/16/2004 | DE19958961B4 Nukleinsäuren zur Herstellung von transgenen Pflanzen mit erhöhter Phytopathogen-Resistenz Nucleic acids for the production of transgenic plants with increased resistance to phytopathogen |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2518187A1 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | CA2518150A1 Methods and compositions involving mda-7 |
| 09/16/2004 | CA2518046A1 Screening method for genes of brewing yeast |
| 09/16/2004 | CA2517981A1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp |
| 09/16/2004 | CA2517953A1 Novel gene relating to fibrotic conditions |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/16/2004 | CA2517899A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2517879A1 Enhanced amylose production in plants |
| 09/16/2004 | CA2517857A1 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | CA2517767A1 Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof |
| 09/16/2004 | CA2517601A1 Infectious flavivirus pseudo-particles containing functional prm-e envelope proteins |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517518A1 Streptococcus pyogenes antigens |
| 09/16/2004 | CA2517158A1 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | CA2517101A1 A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | CA2516519A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/15/2004 | EP1457565A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 09/15/2004 | EP1457558A1 WEED CONTROLLER METABOLISM PROTEINS, GENES THEREOF AND USE OF THE SAME |
| 09/15/2004 | EP1457557A1 Novel proteins and dnas thereof |
| 09/15/2004 | EP1457555A1 Methods for identifying gibberellin responsive genes using cultured plant cells |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1457498A1 Novel peptide having angiotensin convertase inhibitory effect |
| 09/15/2004 | EP1457497A1 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/15/2004 | EP1457211A1 Recombinant vaccinia virus vaccine |
| 09/15/2004 | EP1457210A1 Remedies and/or preventives for conformational diseases |
| 09/15/2004 | EP1456662A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis |
| 09/15/2004 | EP1456656A2 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 09/15/2004 | EP1456655A2 Receptors and membrane-associated proteins |
| 09/15/2004 | EP1456654A2 Use of elavl-1 gene in the detection and modulation of apoptosis |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456652A2 Agents that modulate immune cell activation and methods of use thereof |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456418A2 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456397A2 52908, a human potassium channel, and uses thereof |
| 09/15/2004 | EP1456394A2 Methods of using improved polymerases |
| 09/15/2004 | EP1456392A2 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 09/15/2004 | EP1456390A2 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 09/15/2004 | EP1456387A2 Expression vector for the production of annexin v |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456381A1 Human prostate cancer candidate protein 1 |
| 09/15/2004 | EP1456379A2 Compositions and methods for modulating plant development |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456376A2 Novel chimeric rev, tat, and nef antigens |
| 09/15/2004 | EP1456373A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 09/15/2004 | EP1456372A2 Emission ratiometric indicators of phosphorylation |
| 09/15/2004 | EP1456368A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456363A1 Alleles of the siga gene from coryneform bacteria |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456358A2 Cultured stromal cells and uses thereof |
| 09/15/2004 | EP1456349A2 Expression system |